{"nctId":"NCT00619957","briefTitle":"Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis","startDateStruct":{"date":"2002-06"},"conditions":["Other Osteoporosis"],"count":285,"armGroups":[{"label":"1","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo tablet"]},{"label":"Risedronate","type":"EXPERIMENTAL","interventionNames":["Drug: Risedronate"]}],"interventions":[{"name":"Placebo tablet","otherNames":[]},{"name":"Risedronate","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Documented osteoporosis of the femoral neck and lumbar spine\n\nExclusion Criteria:\n\n* BMI greater than or equal to 35","healthyVolunteers":false,"sex":"MALE","minimumAge":"30 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percent Change From Baseline in Lumbar Spine Bone Mineral Density (BMD), 24 Months/Endpoint, ITT Population.","description":"DXA (dual energy x-ray absorptiometry) assayed on Lunar or Hologic machines. Site will perform at screening to determine if scan should be forwarded to central facility for analysis. Mean of 2 scans performed read by central lab to determine entry qualification. Results standardized (sBMD): Hologic sBMD = 1000 x (BMD x 1.0755), Lunar sBMD = 1000 x (BMD x 0.9522).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.22","spread":null},{"groupId":"OG001","value":"5.75","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Lumbar Spine BMD, Month 6, ITT Population.","description":"DXA (dual energy x-ray absorptiometry) assayed on Lunar or Hologic machines and forwarded to central laboratory for reading.DXA (dual energy x-ray absorptiometry) assayed on Lunar or Hologic machines. Results standardized (sBMD): Hologic sBMD = 1000 x (BMD x 1.0755), Lunar sBMD = 1000 x (BMD x 0.9522).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.03","spread":null},{"groupId":"OG001","value":"3.60","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Lumbar Spine BMD, Month 12, ITT Population.","description":"DXA (dual energy x-ray absorptiometry) assayed on Lunar or Hologic machines and forwarded to central laboratory for reading. Results standardized (sBMD): Hologic sBMD = 1000 x (BMD x 1.0755), Lunar sBMD = 1000 x (BMD x 0.9522).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.42","spread":null},{"groupId":"OG001","value":"4.60","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Lumbar Spine BMD, Month 24, ITT Population.","description":"DXA (dual energy x-ray absorptiometry) assayed on Lunar or Hologic machines and forwarded to central laboratory for reading. Mean of 2 scans performed. Results standardized (sBMD): Hologic sBMD = 1000 x (BMD x 1.0755), Lunar sBMD = 1000 x (BMD x 0.9522).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.40","spread":null},{"groupId":"OG001","value":"5.98","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Proximal Femur BMD, Month 6, ITT Population.","description":"DXA (dual energy x-ray absorptiometry) assayed on Lunar or Hologic machines and forwarded to central laboratory for reading. Results standardized (sBMD): Hologic sBMD = 1000 x (1.008 x BMD + 0.006), Lunar sBMD = 1000 x (0.979 x BMD - 0.031).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.76","spread":null},{"groupId":"OG001","value":"1.16","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Proximal Femur BMD, Month 12, ITT Population.","description":"DXA (dual energy x-ray absorptiometry) assayed on Lunar or Hologic machines and forwarded to central laboratory for reading. Results standardized (sBMD): Hologic sBMD = 1000 x (1.008 x BMD + 0.006), Lunar sBMD = 1000 x (0.979 x BMD - 0.031).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.74","spread":null},{"groupId":"OG001","value":"1.38","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Proximal Femur BMD, Month 24, ITT Population.","description":"DXA (dual energy x-ray absorptiometry) assayed on Lunar or Hologic machines. Scans will be forwarded to central facility for analysis. Mean of 2 scans performed will be utilized. Results standardized (sBMD): Hologic sBMD = 1000 x (1.008 x BMD + 0.006), Lunar sBMD = 1000 x (0.979 x BMD - 0.031).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.06","spread":null},{"groupId":"OG001","value":"1.76","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Proximal Femur BMD, 24 Months/Endpoint, ITT Population.","description":"DXA (dual energy x-ray absorptiometry) assayed on Lunar or Hologic machines. Scans will be forwarded to central facility for analysis. Mean of 2 scans performed will be utilized. Results standardized (sBMD): Hologic sBMD = 1000 x (1.008 x BMD + 0.006), Lunar sBMD = 1000 x (0.979 x BMD - 0.031).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.24","spread":null},{"groupId":"OG001","value":"1.71","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Femoral Neck BMD, Month 6, ITT Population.","description":"DXA (dual energy x-ray absorptiometry) assayed on Lunar or Hologic machines. Scans will be forwarded to central facility for analysis. Baseline femoral neck values measured on Lunar instruments will be normalized to Hologic reference. Hologic Reference BMD = (0.836 x BMD\\[lunar\\]) - 0.008","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.48","spread":null},{"groupId":"OG001","value":"0.98","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Femoral Neck BMD, Month 12, ITT Population.","description":"DXA (dual energy x-ray absorptiometry) assayed on Lunar or Hologic machines. Scans will be forwarded to central facility for analysis. Baseline femoral neck values measured on Lunar instruments will be normalized to Hologic reference. Hologic reference BMD = (0.836 x BMD\\[lunar\\]) - 0.008","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.62","spread":null},{"groupId":"OG001","value":"1.49","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Femoral Neck BMD, Month 24, ITT Population.","description":"DXA (dual energy x-ray absorptiometry) assayed on Lunar or Hologic machines. Scans will be forwarded to central facility for analysis. Mean of 2 scans performed will be utilized. Baseline femoral neck values measured on Lunar instruments will be normalized to Hologic reference. Hologic reference BMD = (0.836 x BMD\\[lunar\\]) - 0.008","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.42","spread":null},{"groupId":"OG001","value":"1.65","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Femoral Neck BMD, 24 Months/Endpoint, ITT Population.","description":"DXA (dual energy x-ray absorptiometry) assayed on Lunar or Hologic machines. Scans will be forwarded to central facility for analysis. Mean of 2 scans performed will be utilized. Baseline femoral neck values measured on Lunar instruments will be normalized to Hologic reference. Hologic reference BMD = (0.836 x BMD\\[lunar\\]) - 0.008","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.53","spread":null},{"groupId":"OG001","value":"1.59","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Femoral Trochanter BMD, Month 6, ITT Population.","description":"DXA (dual energy x-ray absorptiometry) assayed on Lunar or Hologic machines. Scans will be forwarded to central facility for analysis.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.67","spread":null},{"groupId":"OG001","value":"1.24","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Femoral Trochanter BMD, Month 12, ITT Population.","description":"DXA (dual energy x-ray absorptiometry) assayed on Lunar or Hologic machines. Scans will be forwarded to central facility for analysis.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.81","spread":null},{"groupId":"OG001","value":"1.89","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Femoral Trochanter BMD, Month 24, ITT Population.","description":"DXA (dual energy x-ray absorptiometry) assayed on Lunar or Hologic machines. Scans will be forwarded to central facility for analysis.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.52","spread":null},{"groupId":"OG001","value":"2.83","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Femoral Trochanter BMD, 24 Months/Endpoint, ITT Population.","description":"DXA (dual energy x-ray absorptiometry) assayed on Lunar or Hologic machines. Scans will be forwarded to central facility for analysis.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.57","spread":null},{"groupId":"OG001","value":"2.73","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in CTx (Type I Collagen C-telopeptide), Month 3, ITT Population.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.56","spread":null},{"groupId":"OG001","value":"-58.16","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in CTx, Month 6, ITT Population.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-13.72","spread":null},{"groupId":"OG001","value":"-58.44","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in CTx, Month 12, ITT Population.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-19.12","spread":null},{"groupId":"OG001","value":"-61.46","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in CTx, Month 24, ITT Population.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.28","spread":null},{"groupId":"OG001","value":"-37.27","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in CTx, 24 Months/Endpoint, ITT Population.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.39","spread":null},{"groupId":"OG001","value":"-38.76","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in NTx/Cr (Type I Collagen N-telopeptide/Creatinine), Month 3, ITT Population.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-17.41","spread":null},{"groupId":"OG001","value":"-33.28","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in NTx/Cr, Month 6, ITT Population.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.98","spread":null},{"groupId":"OG001","value":"-29.97","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in NTx/Cr, Month 12, ITT Population.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-16.46","spread":null},{"groupId":"OG001","value":"-38.42","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in NTx/Cr, Month 24, ITT Population.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-22.27","spread":null},{"groupId":"OG001","value":"-37.38","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in NTx/Cr, 24 Months/Endpoint, ITT Population.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-20.45","spread":null},{"groupId":"OG001","value":"-36.82","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in BAP (Bone-specific Alkaline Phosphatase), Month 3, ITT Population.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.89","spread":null},{"groupId":"OG001","value":"-24.53","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in BAP, Month 6, ITT Population.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.68","spread":null},{"groupId":"OG001","value":"-29.78","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in BAP, Month 12, ITT Population.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.11","spread":null},{"groupId":"OG001","value":"-29.51","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in BAP, Month 24, ITT Population.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.95","spread":null},{"groupId":"OG001","value":"-25.20","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in BAP, 24 Months/Endpoint, ITT Population.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.99","spread":null},{"groupId":"OG001","value":"-25.27","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Body Height, Month 12, ITT Population.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.77","spread":null},{"groupId":"OG001","value":"-0.92","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Body Height, Month 24, ITT Population.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.66","spread":null},{"groupId":"OG001","value":"-3.13","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Body Height, 24 Months/Endpoint, ITT Population.","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.39","spread":null},{"groupId":"OG001","value":"-2.68","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent of Responders Lumbar Spine BMD, Month 24, ITT Population","description":"responder = positive change (\\>0) in lumbar spine BMD from Baseline to Month 24","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"60.3","spread":null},{"groupId":"OG001","value":"89.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Cumulative Incidence of Fractures, 12 Months, ITT Population","description":"Kaplan-Meier Cumulative Incidence, fractures / 100 patients / year","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.4","spread":null},{"groupId":"OG001","value":"2.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Cumulative Incidence of Fractures, 24 Months, ITT Population","description":"Kaplan-Meier Cumulative Incidence, fractures / 100 patients / 2 years","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.7","spread":null},{"groupId":"OG001","value":"4.9","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":15,"n":93},"commonTop":["Nasopharyngitis","Arthralgia","Back Pain","Constipation","Hypertension"]}}}